With a number of core technologies and patented technologies in the field of medical imaging
the cardiovascular imaging intelligent analysis platform is built based on artificial intelligence, cloud computing and big data.
Platform Services
Cardiovascular Imaging Intelligent Analysis Cloud Platform Service
-
CT-FFR cloud computing
（CTA image post-processing, automatic output FFR diagnostic criteria report）
-
Coronary heart disease surgery planning assessment
（Bridge, stent surgery pre-assessment, planning the best treatment plan）
-
Intelligent analysis of coronary heart disease
（3D reconstruction of blood vessels, calcification integral calculation, vulnerable plaque recognition, etc.）
-
Aortic dissection intelligent analysis
（automatic segmentation of aortic dissection）
-
Intelligent processing of cardiac magnetic images
（Heart nuclear magnetic image automated annotation processing）
-
Custom service
（Customized solutions for different hospital needs）
Core Product
Functional Evaluation of Coronary Artery Stenosis — CT-FFR
-
Non-invasive
-
low-cost
-
efficient
CT-FFR
Our company independently developed the CT-FFR, a functional evaluation program for coronary artery stenosis, which effectively solved the non-invasive measurement problem of FFR and was inexpensive. Using artificial intelligence to analyze coronary CT data, simulation calculations to obtain FFR values, to provide a basis for decision-making for subsequent treatment options.
Learn more
Expert Reviews
James Min(Director, Cardiovascular Imaging Center, Cornell Medical College)
The use of non-invasive FFR has been shown to have a better diagnostic value for all patients and all blood vessels than CT alone.
Raymond Dalio( the godfather of the hedge fund)
After learning about non-invasive FFR technology in 2013, he donated $20 million to Cornell Medical College to establish a cardiovascular imaging center.
William Maisel(Chief Scientist, FDA Equipment and Radiological Health Center)
"This non-invasive diagnostic technology provides a new tool for physicians who are considering the risks and benefits of coronary surgery."
Zhou Yujie(Deputy Dean of Anzhen Hospital)
Compared with FFR, FFFCT determined that the accuracy, specificity, positive and negative predictive value of myocardial ischemic lesions have a good correlation with FFR, and highly suggest that noninvasive evaluation is an inevitable trend in the development of cardiology, and also indicates coronary artery. The evaluation and treatment of lesions will be fully advanced to a new era of combination of morphology and function. At present, Anzhen Hospital has also carried out research on virtual coronary intervention, in order to optimize the choice of patients for invasive treatment, and to plan the entire treatment strategy through this technology.
Lu Bin(Director, Department of Radiology, Fuwai Hospital)
Because FFRCT has a wide range of clinical applications, it is non-invasive. On the basis of a coronary anatomical assessment completed in one scan, the functional parameters of the lesion can be obtained without rescanning. I believe that it must have broad application prospects.
Xu Yawei(Director, Department of Cardiology,The Tenth People's Hospital affiliated to Tongji University)
"FFR-CT, a new technology, brings new hope to the early diagnosis of coronary heart disease, and it will have broad application prospects."
Beijing Heart Century Medical Technology Co., Ltd. was established in 2017. The company is committed to using artificial intelligence technology to transform the medical industry and contribute to life and health. The company currently has a number of core technologies and patented technologies in the field of medical imaging. Based on artificial intelligence, cloud computing and big data, the company has built a cardiovascular imaging intelligent analysis platform to provide better detection and treatment services for heart disease patients. The core team consists of Tsinghua University and overseas students, as well as artificial intelligence experts and medical experts with many years of experience in medical imaging. The core technology of the product has been completed and verified at home and abroad, reaching the international leading level.
Cooperative organization
阜外医院
朝阳医院
清华工研院
齐鲁医院
邵逸夫医院
Add：Block D 310, Building 2, Dongsheng International Science Park, 1 Yongtaizhuang North Road, Haidian District, Beijing 
Contact：info@heartcentury.com
Apply：hr@heartcentury.com
Heart Century WeChat Public